You can buy or sell PerkinElmer and other stocks, options, ETFs, and crypto commission-free!
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. Read More The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.
52 Week High
52 Week Low
Global Lab Automation for In-Vitro Diagnostic Market Outlook (2019 to 2027) - Featuring Tecan Group, Roche Holding & PerkinElmer Among Others
Dublin, July 01, 2020 (GLOBE NEWSWIRE) -- The "Lab Automation For In-Vitro Diagnostic - Global Market Outlook (2019-2027)" report has been added to ResearchAndM
— per share
Expected Jul 29, After Hours